Sculptor Capital’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$684K Sell
89,200
-529,800
-86% -$3.63M 0.01% 259
2025
Q4
$1.23M Hold
619,000
0.01% 267
2025
Q3
$1.52M Buy
619,000
+310,400
+101% +$799K 0.02% 239
2025
Q2
$815K Buy
+308,600
New +$830K 0.01% 256
2025
Q1
Sell
-270,800
Closed -$821K 366
2024
Q4
$693K Buy
270,800
+53,000
+24% +$221K 0.01% 229
2024
Q3
$810K Buy
217,800
+95,300
+78% +$441K 0.02% 205
2024
Q2
$774K Sell
122,500
-143,700
-54% -$947K 0.02% 173
2024
Q1
$1.43M Buy
266,200
+186,700
+235% +$845K 0.03% 148
2023
Q4
$399K Sell
79,500
-51,800
-39% -$163K 0.01% 209
2023
Q3
$222K Hold
131,300
0.01% 233
2023
Q2
$365K Buy
131,300
+82,100
+167% +$232K 0.01% 222
2023
Q1
$89.5K Hold
49,200
﹤0.01% 319
2022
Q4
$249K Hold
49,200
﹤0.01% 478
2022
Q3
$245K Buy
+49,200
New +$224K ﹤0.01% 653
2022
Q1
Sell
-153,300
Closed -$932K 1270
2021
Q4
$932K Sell
153,300
-4,800
-3% -$36.1K 0.01% 688
2021
Q3
$1.54M Hold
158,100
0.01% 516
2021
Q2
$2.26M Hold
158,100
0.02% 487
2021
Q1
$3.75M Buy
158,100
+151,300
+2,225% +$3.92M 0.03% 327
2020
Q4
$91K Buy
+6,800
New +$65.4K ﹤0.01% 469

Other funds holding IBRX